Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Pfizer
company
Investments
Number of Investments
Number of Lead Investments
44
19
Pfizer has made 44 investments. Their most recent investment was on
Dec 21, 2022, when ORIC Pharmaceuticals, Inc raised
| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Dec 21, 2022 | ORIC Pharmaceuticals | Post-IPO Equity | — | Biotechnology | Yes |
| Dec 1, 2022 | Carrick Therapeutics | Series C | — | Biotechnology | Yes |
| Sep 20, 2022 | CytoReason | Corporate Round | — | Biopharma | Yes |
| Jun 20, 2022 | Valneva | Post-IPO Equity | — | Biotechnology | Yes |
| Jun 14, 2022 | Dren Bio | Series B | — | Biotechnology | — |
| Apr 27, 2022 | Zentalis Pharmaceuticals | Post-IPO Equity | — | Biopharma | Yes |
| Apr 26, 2022 | Resistell AG | Grant | — | Medical Device | Yes |
| Apr 5, 2022 | National Eczema Association | Grant | — | Yes | |
| Jan 18, 2022 | Sema4 | Post-IPO Equity | — | Artificial Intelligence | — |
| Nov 4, 2021 | The National Comprehensive Cancer Network (NCCN) | Grant | — | Health Care | — |
| Jun 30, 2021 | Spero Therapeutics | Post-IPO Equity | — | Biotechnology | Yes |
| Feb 17, 2021 | Imcyse | Series B | — | Biotechnology | Yes |
| Oct 29, 2020 | LianBio | Series A | — | Biopharma | — |
| Aug 10, 2020 | ESSA Pharma | Post-IPO Equity | — | Biopharma | — |
| Jul 29, 2020 | Cerevel Therapeutics | Post-IPO Equity | — | Biotechnology | — |
| May 19, 2020 | Amplyx Pharmaceuticals | Series C | — | Biotechnology | — |
| Apr 22, 2020 | FoRx Therapeutics | Seed | — | Biotechnology | — |
| Jan 8, 2020 | EvolveImmune Therapeutics | Series Unknown | — | Biotechnology | Yes |
| Mar 20, 2019 | Vivet Therapeutics | Corporate Round | — | Biopharma | Yes |
| Feb 19, 2019 | Gliknik | Corporate Round | — | Biotechnology | Yes |
| Nov 13, 2018 | NextCure | Series B | — | Biopharma | — |
| Apr 19, 2018 | Allogene Therapeutics | Series A | — | Biotechnology | — |
| Apr 25, 2017 | Aquinnah Pharmaceuticals | Series Unknown | — | Health Care | Yes |
| Apr 14, 2017 | Cortexyme | Debt Financing | — | Biotechnology | — |
| Feb 28, 2017 | North Carolina Biotechnology Center | Grant | — | Biotechnology | Yes |
| Feb 27, 2017 | Arrakis Therapeutics | Series A | — | Biopharma | — |
| Jan 16, 2017 | Amra | Series Unknown | — | Health Care | Yes |
| Jan 5, 2017 | Molecular Stethoscope | Seed | — | Biotechnology | — |
| Dec 28, 2016 | DIR Technologies | Funding Round | — | Health Care | Yes |
| Dec 21, 2016 | Circle Pharma | Series A | — | Biotechnology | — |
| Apr 4, 2016 | Metabomed | Series A | — | Biopharma | — |
| Jan 6, 2016 | Cortexyme | Series A | — | Biotechnology | Yes |
| Jan 6, 2016 | NextCure | Series A | — | Biopharma | — |
| Jan 1, 2016 | Imara | Seed | — | Biopharma | — |
| Dec 3, 2015 | M-Tiba | Seed | — | Health Care | — |
| Oct 14, 2015 | Protalix BioTherapeutics | Post-IPO Equity | — | Biotechnology | Yes |
| May 11, 2015 | AM Pharma | Corporate Round | — | Biopharma | — |
| Sep 22, 2014 | Circle Pharma | Seed | — | Biotechnology | — |
| Apr 14, 2010 | Aureon Laboratories | Series D | — | Biotechnology | — |
| Mar 5, 2010 | Aureon Laboratories | Series C | — | Biotechnology | — |
| Jan 29, 2010 | Merus | Series B | — | Biotechnology | Yes |
| Sep 28, 2009 | NovoCure | Series Unknown | — | Health Care | — |
| Jun 2, 2005 | SuperDimension | Series B | — | Health Care | — |
| Sep 19, 2000 | Ventaira Pharmaceuticals | Series A | — | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
